David Colleran - EVP, General Counsel, Corp Sec at Anika Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, General Counsel, Corp Sec
Issuer Symbol
ANIK on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by David Colleran since 11 Mar 2025

Holdings reported by David Colleran for Anika Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 53,100 $510,291 $9.61 09 Mar 2026 Direct
Restricted Stock Unit 0 $205,191 $15.91 09 Mar 2026 Direct Common Stock

Transactions reported by David Colleran for Anika Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.